Sanofi Sales, Profit Beat Forecasts
Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength in anti-inflammatory drug Dupixent and its new drug launches.
STMicroelectronics Cuts Sales Outlook as Demand Slows Read More »
Chinese Bubble Tea Maker Slides in Hong Kong Trading Debut Read More »
GM Raises Profit Outlook for 2024 After Strong First-Quarter Earnings Read More »
Primark Owner AB Foods Profit Rises on Easing Costs Read More »